Melissa Zarandi-Nowroozi, Mahsa Taghiakbari, Alan Barkun, Heiko Pohl, Bénédicte Nauche, Miguel Chagnon, Daniel von Renteln
{"title":"粪便免疫化学检验临界值对腺瘤检出率的影响:系统综述和荟萃分析。","authors":"Melissa Zarandi-Nowroozi, Mahsa Taghiakbari, Alan Barkun, Heiko Pohl, Bénédicte Nauche, Miguel Chagnon, Daniel von Renteln","doi":"10.1080/00365521.2024.2356649","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Adenoma detection rate (ADR) is higher after a positive fecal immunochemical test (FIT) compared to direct screening colonoscopy.</p><p><strong>Objective: </strong>This meta-analysis evaluated how ADR, the rates of advanced adenoma detection (AADR), colorectal cancer detection (CDR), and sessile serrated lesion detection (SSLDR) are affected by different FIT positivity thresholds.</p><p><strong>Methods: </strong>We searched MEDLINE, EMBASE, CINAHL, and EBM Reviews databases for studies reporting ADR, AADR, CDR, and SSLDR according to different FIT cut-off values in asymptomatic average-risk individuals aged 50-74 years old. Data were stratified according to sex, age, time to colonoscopy, publication year, continent, and FIT kit type. Study quality, heterogeneity, and publication bias were assessed.</p><p><strong>Results: </strong>Overall, 4280 articles were retrieved and fifty-eight studies were included (277,661 FIT-positive colonoscopies; mean cecal intubation 96.3%; mean age 60.8 years; male 52.1%). Mean ADR was 56.1% (95% CI 53.4 - 58.7%), while mean AADR, CDR, and SSLDR were 27.2% (95% CI 24.4 - 30.1%), 5.3% (95% CI 4.7 - 6.0%), and 3.0% (95% CI 1.7 - 4.6%), respectively. For each 20 μg Hb/g increase in FIT cut-off level, ADR increased by 1.54% (95% CI 0.52 - 2.56%, <i>p</i> < 0.01), AADR by 3.90% (95% CI 2.76 - 5.05%, <i>p</i> < 0.01) and CDR by 1.46% (95% CI 0.66 - 2.24%, <i>p</i> < 0.01). Many detection rates were greater amongst males and Europeans.</p><p><strong>Conclusions: </strong>ADRs in FIT-positive colonoscopies are influenced by the adopted FIT positivity threshold, and identified targets, importantly, proved to be higher than most current societal recommendations.</p>","PeriodicalId":21461,"journal":{"name":"Scandinavian Journal of Gastroenterology","volume":" ","pages":"882-892"},"PeriodicalIF":1.6000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effect of fecal immunochemical test cut-off levels on adenoma detection rate: a systematic review and meta-analysis.\",\"authors\":\"Melissa Zarandi-Nowroozi, Mahsa Taghiakbari, Alan Barkun, Heiko Pohl, Bénédicte Nauche, Miguel Chagnon, Daniel von Renteln\",\"doi\":\"10.1080/00365521.2024.2356649\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Adenoma detection rate (ADR) is higher after a positive fecal immunochemical test (FIT) compared to direct screening colonoscopy.</p><p><strong>Objective: </strong>This meta-analysis evaluated how ADR, the rates of advanced adenoma detection (AADR), colorectal cancer detection (CDR), and sessile serrated lesion detection (SSLDR) are affected by different FIT positivity thresholds.</p><p><strong>Methods: </strong>We searched MEDLINE, EMBASE, CINAHL, and EBM Reviews databases for studies reporting ADR, AADR, CDR, and SSLDR according to different FIT cut-off values in asymptomatic average-risk individuals aged 50-74 years old. Data were stratified according to sex, age, time to colonoscopy, publication year, continent, and FIT kit type. Study quality, heterogeneity, and publication bias were assessed.</p><p><strong>Results: </strong>Overall, 4280 articles were retrieved and fifty-eight studies were included (277,661 FIT-positive colonoscopies; mean cecal intubation 96.3%; mean age 60.8 years; male 52.1%). Mean ADR was 56.1% (95% CI 53.4 - 58.7%), while mean AADR, CDR, and SSLDR were 27.2% (95% CI 24.4 - 30.1%), 5.3% (95% CI 4.7 - 6.0%), and 3.0% (95% CI 1.7 - 4.6%), respectively. For each 20 μg Hb/g increase in FIT cut-off level, ADR increased by 1.54% (95% CI 0.52 - 2.56%, <i>p</i> < 0.01), AADR by 3.90% (95% CI 2.76 - 5.05%, <i>p</i> < 0.01) and CDR by 1.46% (95% CI 0.66 - 2.24%, <i>p</i> < 0.01). Many detection rates were greater amongst males and Europeans.</p><p><strong>Conclusions: </strong>ADRs in FIT-positive colonoscopies are influenced by the adopted FIT positivity threshold, and identified targets, importantly, proved to be higher than most current societal recommendations.</p>\",\"PeriodicalId\":21461,\"journal\":{\"name\":\"Scandinavian Journal of Gastroenterology\",\"volume\":\" \",\"pages\":\"882-892\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Scandinavian Journal of Gastroenterology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/00365521.2024.2356649\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/5/22 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scandinavian Journal of Gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/00365521.2024.2356649","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/22 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:与直接筛查结肠镜相比,粪便免疫化学试验(FIT)阳性后的腺瘤检出率(ADR)更高:这项荟萃分析评估了不同的 FIT 阳性阈值对 ADR、晚期腺瘤检出率 (AADR)、结直肠癌检出率 (CDR) 和无柄锯齿状病变检出率 (SSLDR) 的影响:我们检索了 MEDLINE、EMBASE、CINAHL 和 EBM Reviews 数据库,以查找根据不同 FIT 临界值对 50-74 岁无症状高危人群进行 ADR、AADR、CDR 和 SSLDR 检测的研究。根据性别、年龄、结肠镜检查时间、发表年份、大陆和 FIT 套件类型对数据进行了分层。对研究质量、异质性和发表偏倚进行了评估:共检索到 4280 篇文章,纳入了 58 项研究(277661 例 FIT 阳性结肠镜检查;平均盲肠插管率 96.3%;平均年龄 60.8 岁;男性 52.1%)。平均 ADR 为 56.1%(95% CI 53.4 - 58.7%),平均 AADR、CDR 和 SSLDR 分别为 27.2%(95% CI 24.4 - 30.1%)、5.3%(95% CI 4.7 - 6.0%)和 3.0%(95% CI 1.7 - 4.6%)。FIT 临界值每增加 20 μg Hb/g,ADR 增加 1.54%(95% CI 0.52 - 2.56%,p p p 结论:FIT 阳性结肠镜检查中的 ADR 受所采用的 FIT 阳性临界值的影响,重要的是,已确定的目标值高于目前大多数社会建议值。
Effect of fecal immunochemical test cut-off levels on adenoma detection rate: a systematic review and meta-analysis.
Background: Adenoma detection rate (ADR) is higher after a positive fecal immunochemical test (FIT) compared to direct screening colonoscopy.
Objective: This meta-analysis evaluated how ADR, the rates of advanced adenoma detection (AADR), colorectal cancer detection (CDR), and sessile serrated lesion detection (SSLDR) are affected by different FIT positivity thresholds.
Methods: We searched MEDLINE, EMBASE, CINAHL, and EBM Reviews databases for studies reporting ADR, AADR, CDR, and SSLDR according to different FIT cut-off values in asymptomatic average-risk individuals aged 50-74 years old. Data were stratified according to sex, age, time to colonoscopy, publication year, continent, and FIT kit type. Study quality, heterogeneity, and publication bias were assessed.
Results: Overall, 4280 articles were retrieved and fifty-eight studies were included (277,661 FIT-positive colonoscopies; mean cecal intubation 96.3%; mean age 60.8 years; male 52.1%). Mean ADR was 56.1% (95% CI 53.4 - 58.7%), while mean AADR, CDR, and SSLDR were 27.2% (95% CI 24.4 - 30.1%), 5.3% (95% CI 4.7 - 6.0%), and 3.0% (95% CI 1.7 - 4.6%), respectively. For each 20 μg Hb/g increase in FIT cut-off level, ADR increased by 1.54% (95% CI 0.52 - 2.56%, p < 0.01), AADR by 3.90% (95% CI 2.76 - 5.05%, p < 0.01) and CDR by 1.46% (95% CI 0.66 - 2.24%, p < 0.01). Many detection rates were greater amongst males and Europeans.
Conclusions: ADRs in FIT-positive colonoscopies are influenced by the adopted FIT positivity threshold, and identified targets, importantly, proved to be higher than most current societal recommendations.
期刊介绍:
The Scandinavian Journal of Gastroenterology is one of the most important journals for international medical research in gastroenterology and hepatology with international contributors, Editorial Board, and distribution